Trial Profile
To compare the efficacy of Ezeimibe and rosuvastatin versus high dose rosuvastatin in chinese patients with non-ST elevation acute coronary syndrome
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Dec 2017
Price :
$35
*
At a glance
- Drugs Ezetimibe (Primary) ; Rosuvastatin
- Indications Acute coronary syndromes
- Focus Therapeutic Use
- 19 Dec 2017 New trial record